Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis

Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis

Ulcerative colitis (UC), a relapsing-remitting chronic inflammatory bowel disease (IBD), has a variable natural course but potentially severe disease course. Since the development of anti-tumor necrosis factor (TNF) agents has changed the natural disease course of moderate-to-severe UC, therapeutic...

Full description

Bibliographic Details
Main Authors: Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2023-01-01
Series:Intestinal Research
Subjects:
colitis, ulcerative
inflammatory bowel disease
management
guideline
Online Access:http://www.irjournal.org/upload/pdf/ir-2022-00007.pdf

Internet

http://www.irjournal.org/upload/pdf/ir-2022-00007.pdf

Similar Items